Pharmafile Logo

News and Press Releases

CARBOGEN AMCIS Announces Leadership Transition

3 February 2025 – Bubendorf, Switzerland –Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal...

Category:
Posted: February 3, 2025

CARBOGEN AMCIS
info@carbogen-amcis.com
Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site

January 13 2025 – Bubendorf, Switzerland — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...

Category: Pharmaceutical
Posted: January 16, 2025

CARBOGEN AMCIS
info@carbogen-amcis.com
Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site

13 January 2025 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 13, 2025

CARBOGEN AMCIS
info@carbogen-amcis.com
Hauptstrasse 171 CH-4416 Bubendorf Switzerland

CARBOGEN AMCIS Announces Two Successful FDA Inspections at its Manufacturing Sites in Neuland and Aarau, Switzerland

23 July 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...

Category: BioManufacturing, Other, Pharmaceutical
Posted: July 23, 2024

CARBOGEN AMCIS
info@carbogen-amcis.com
Hauptstrasse 171 CH-4416 Bubendorf Switzerland

Celonic Inaugurates “Next Generation” Biologics Development Centre (BDC) and Pilot Plant in Basel, Switzerland

The Celonic Group, a “Pure Play” Biologics contract development and manufacturing organisation (CDMO), expands process development and optimisation services in Basel Investment builds on “Next Generation” bioprocessing capability and pilot...

Category: BioManufacturing, Pharmaceutical
Posted: June 18, 2024

Celonic
Elisa.Witt@celonic.com
Eulerstrasse 55 CH - 4051 Basel

Celonic Launches New GS-CHOvolution Cell Line Expression System

GS-CHOvolution is based on Revvity’s CHOSOURCE expression platform and TnT transposon technology 8 April 2024 -- Basel, Switzerland -- Celonic has signed a commercial license agreement with Revvity for its CHOSOURCE...

Category: BioManufacturing
Posted: April 8, 2024

Celonic
Elisa.Witt@celonic.com
Eulerstrasse 55 CH - 4051 Basel

CARBOGEN AMCIS announces successful ANVISA audit of its facility in China

19 March 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory...

Category: BioManufacturing
Posted: March 19, 2024

CARBOGEN AMCIS
info@carbogen-amcis.com
Hauptstrasse 171 CH-4416 Bubendorf Switzerland